1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,023 | 0,032 | 20.09. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.09. | Bioretec Oy: Bioretec receives FDA 510(k) clearance for its ActivaScrew Cannulated COM bioabsorbable compression screw | 179 | GlobeNewswire (Europe) | Bioretec Ltd. | Inside information | 5 September 2026 at 12:25 p.m. EEST
Bioretec Ltd ("Bioretec" or the "Company"), a pioneer in bioabsorbable orthopedic implants, has received 510(k) clearance from... ► Artikel lesen | |
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 13.08. | Bioretec Oy: Bioretec Ltd's Half-year report 2026: H1 close signals momentum | 251 | GlobeNewswire (Europe) | Bioretec Ltd. | Company announcement | 13 August 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's half-year report for January-June 2026. The complete half-year report is attached to this... ► Artikel lesen | |
| 05.08. | Bioretec Oy: Panu Mikkonen appointed as Chief Financial Officer of Bioretec | 250 | GlobeNewswire (Europe) | Bioretec Ltd | Company announcement | 5 August 2026 at 4:00 p.m. EESTBioretec Ltd, a pioneer in absorbable orthopedic implants, appoints Panu Mikkonen (M.Sc. Econ) as Chief Financial Officer, effective... ► Artikel lesen | |
| 02.07. | Bioretec Oy: Inside information: Chief Financial Officer Tuukka Paavola will leave the company | 479 | GlobeNewswire (Europe) | Bioretec Ltd, Inside Information, 2 July 2026 at 14.30 EESTBioretec Ltd and Tuukka Paavola have mutually agreed that Paavola will not continue in his position. Paavola will leave his role with immediate... ► Artikel lesen | |
| 17.06. | Bioretec appoints Conan Cavanagh as Head of Research & Development and member of the Management Team | 2 | Cision News | ||
| 17.06. | Bioretec concludes change negotiations | 2 | Cision News | ||
| 04.06. | Bioretec Ltd - Manager's transactions - van Hellenberg Hubar-Fisher | 4 | Cision News | ||
| 02.06. | Bioretec Ltd - Manager's transactions - Jordy Winters | 307 | PR Newswire | TAMPERE, Finland, June 2, 2026 /PRNewswire/ -- Bioretec Oy Company release 2 June 2026 at 13:25 p.m. EEST
Bioretec Oy - Managers' TransactionsPerson subject to the notification requirementName:... ► Artikel lesen | |
| 01.06. | Inside information: Bioretec initiates new change negotiations in production to enhance operational efficiency | 463 | PR Newswire | Bioretec Ltd - Inside information - 1 June 2026 at 19:00 EESTTAMPERE, Finland, June 1, 2026 /PRNewswire/ -- Bioretec Ltd initiates change negotiations in accordance with the Finnish Act on... ► Artikel lesen | |
| 01.06. | The Board of Directors of Bioretec Ltd resolved on a new stock option plan | 430 | PR Newswire | TAMPERE, Finland, June 1, 2026 /PRNewswire/ -- Bioretec Ltd Company Announcement -1 June 2026 at 19:05 p.m. EEST
The Board of Directors of Bioretec Ltd has resolved to establish a new... ► Artikel lesen | |
| 15.05. | Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy | 610 | PR Newswire | TAMPERE, Finland, May 15, 2026 /PRNewswire/ -- Bioretec Ltd. | Company announcement | 15 May 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's business review for January-March... ► Artikel lesen | |
| 15.05. | Bioretec Oy: Bioretec Ltd's business review Q1 2026: Early Traction from Renewed Strategy | 447 | GlobeNewswire (Europe) | Bioretec Ltd. | Company announcement | 15 May 2026 at 9:00 a.m.
This announcement summarizes Bioretec Ltd's business review for January-March 2026. The complete business review is attached to this... ► Artikel lesen | |
| 13.05. | Bioretec clarifies its 2026-2028 financial target regarding the sales margin | 501 | PR Newswire | Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EESTHELSINKI, May 13, 2026 /PRNewswire/ -- To be aligned with industry reporting standards, Bioretec will transition to reporting an... ► Artikel lesen | |
| 13.05. | Bioretec Oy: Bioretec clarifies its 2026-2028 financial target regarding the sales margin | 299 | GlobeNewswire (Europe) | Bioretec Ltd Company release 13 May 2026 at 14:00 p.m. EEST
Bioretec clarifies its 2026-2028 financial target regarding the sales marginTo be aligned with industry reporting standards, Bioretec will... ► Artikel lesen | |
| 08.05. | Bioretec Ltd's resolutions of the constitutive meeting of the Board of Directors | 512 | PR Newswire | HELSINKI, May 8, 2026 /PRNewswire/ -- Bioretec Ltd Company release 8 May 2026 at 20:40 p.m. EEST
Bioretec Ltd's resolutions of the constitutive meeting of the Board of DirectorsAt its... ► Artikel lesen | |
| 08.05. | Bioretec Ltd's resolutions of the Annual General Meeting | 546 | PR Newswire | HELSINKI, May 8, 2026 /PRNewswire/ -- Bioretec Ltd Company release 8 May 2026 at 14:45 p.m. EEST
Bioretec Ltd's resolutions of the Annual General Meeting Bioretec Ltd's Annual General... ► Artikel lesen | |
| 08.05. | Bioretec Oy: Bioretec Ltd's resolutions of the Annual General Meeting | 275 | GlobeNewswire (Europe) | Bioretec Ltd Company release 8 May 2026 at 14:45 p.m. EEST
Bioretec Ltd's resolutions of the Annual General Meeting
Bioretec Ltd's Annual General Meeting was held on Friday 8 May 2026 as a hybrid... ► Artikel lesen | |
| 29.04. | Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Sp-Rahastoyhtiö) | 390 | PR Newswire | HELSINKI, April 29, 2026 /PRNewswire/ -- Bioretec Ltd Company release 29 April 2026 at 16:40 p.m. EEST
Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities... ► Artikel lesen | |
| 28.04. | Bioretec Ltd - Manager's transactions - Stephen Industries Inc Oy | 406 | PR Newswire | HELSINKI, April 28, 2026 /PRNewswire/ -- Bioretec Oy Company release 28 April 2026 at 16:55 p.m. EEST
Bioretec Oy - Managers' Transactions____________________________________________Person... ► Artikel lesen | |
| 28.04. | Bioretec Ltd: Notification pursuant to Chapter 9, Section 10 of the Finnish Securities Markets Act (Kustaa Poutiainen) | 448 | PR Newswire | HELSINKI, April 28, 2026 /PRNewswire/ -- Bioretec Ltd Company release 28 April 2026 at 15:55 p.m. EEST
Bioretec Ltd ("Bioretec" or the "Company") has received on 28 April 2026 the following... ► Artikel lesen |
1 2 3 Weiter >>
52 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 12,120 | -0,90 % | Eckert&Ziegler-Aktie im Check am 20.09. (10:44 Uhr): Meine aktuelle Lageeinschätzung | ||
| INTUITIVE SURGICAL | 343,00 | +0,19 % | Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition? | ||
| DRAEGERWERK | 114,00 | -0,87 % | Drägerwerk-Aktie // Dicker Freudensprung | Bei Drägerwerk läuft das Geschäft weiterhin sehr gut. Dies belegen überzeugende Zahlen für das erste Halbjahr. So erhöhte sich der Umsatz um 6,2 Prozent auf rund 1,6 Milliarden Euro. Bereinigt wäre... ► Artikel lesen | |
| INSULET | 123,45 | +0,82 % | Insulet Corp. Q2 Profit Advances | WASHINGTON (dpa-AFX) - Insulet Corp. (PODD) released earnings for its second quarter that Increases, from the same period last yearThe company's earnings totaled $95.0 million, or $1.37 per... ► Artikel lesen | |
| CYTOSORBENTS | 5,570 | -3,13 % | XFRA HQE: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCYTOSORBENTS DL... ► Artikel lesen | |
| GENEDX | 101,09 | -0,01 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| REVENIO GROUP | 13,100 | -0,46 % | Revenio Group Corporation: Revenio updates its strategy for 2027-2029 and provides new financial targets for the strategy period | Revenio Group Corporation | Stock Exchange Release | September 15, 2026 at 09:00:00 EEST
As previously announced, Revenio has undergone a strategic review after the completion of the Visionix acquisition.... ► Artikel lesen | |
| OPTOMED | 1,540 | 0,00 % | Optomed Oyj: Half-year report January - June 2026 | Optomed Plc Stock Exchange Release 14 August 2026 at 9.00, Helsinki
Optomed Plc: Half-year report January - June 2026
April - June 2026
Revenue decreased by 8.6 percent to EUR 3.5 (3.8) million.
Currency-adjusted... ► Artikel lesen | |
| BILLIONTOONE | 105,92 | 0,00 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| FRESENIUS | 45,920 | -0,42 % | BARCLAYS stuft Fresenius SE auf 'Overweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Fresenius mit einem Kursziel von 57,50 Euro auf "Overweight" belassen. Die Veränderungsrate, wesentlicher Parameter... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,770 | -1,69 % | Die perfekte KI-Aktie: Ist die Siemens-Aktie der Top-Pick für den Jahresendspurt? | © Foto: Julian Stratenschulte - dpaBernstein macht Siemens zur Top-Aktienidee fürs zweite Halbjahr: 330 Euro Kursziel, 25 Prozent Luft nach oben. Treiber sind Digital Industries, Smart Infrastructure... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 38,690 | -0,79 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| PROGYNY | 27,130 | 0,00 % | Progyny vor dem Boom?: Wells Fargo sieht bei dieser "Kinderwunsch-Aktie" 42 % Kurspotenzial | © Foto: SOPA Images - Sipa USAWells Fargo traut Progyny 42 Prozent Kurspotenzial zu. Das Geschäft mit Kinderwunsch-Leistungen könnte jetzt zum großen Wachstumstreiber werden Enthaltene Werte: US74340E1038Den... ► Artikel lesen | |
| MIMEDX | 4,770 | 0,00 % | Cantor Fitzgerald reiterates Overweight on MiMedx stock at $8 | ||
| BRIGHTSPRING HEALTH SERVICES | 56,76 | 0,00 % | Here's Why You Should Add BrightSpring Stock to Your Portfolio Now |
BIORETEC OY gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,001 (-2,03 %) liegt der Kurs bei 0,029 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.